ISS-based therapies (Dynavax)

N/A

Report date: 2025/05/14 13:51:45

Base Information

Drug NameISS-based therapies (Dynavax)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccineSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide

Mechanisms of ActionToll like receptor 9 agonists

TargetsToll like receptor 9

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesDynavax Technologies Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTriangle Pharmaceuticals Dynavax Technologies Corp

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A